title: Giant cell arteritis--the methotrexate debate revisited.
authors.forename: Doron
authors.initials: D
authors.lastname: Rimar
authors.forename: Michael
authors.initials: M
authors.lastname: Rozenbaum
authors.forename: Devy
authors.initials: D
authors.lastname: Zisman
authors.forename: Nina
authors.initials: N
authors.lastname: Boulman
authors.forename: Gleb
authors.initials: G
authors.lastname: Slobodin
authors.forename: Lihi
authors.initials: L
authors.lastname: Eder
authors.forename: Joy
authors.initials: J
authors.lastname: Feld
authors.forename: Itzhak
authors.initials: I
authors.lastname: Rosner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001766:Blindness / Q000209:etiology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D013700:Giant Cell Arteritis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate